TP53 and cancer: Substantial potentiation of the anti-tumor activity of gemcitabine (anti-metabolite), camptothecin and SN38 (topoisomerase I inhibitors), and cisplatin (DNA alkylator) by V158411 was observed in all five p53 mutant cancer cell lines but not in the three p53 wild type cell lines.